Operating Expenses 更改
AbbVie USD 11.11B 540M 2023-12
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Acorda Therapeutics USD 33.31M 427K 2023-06
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Incyte USD 826.07M 121.75M 2023-12
Insmed USD 261.96M 35.22M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
United Therapeutics USD 354.6M 72.2M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Vertex Pharmaceuticals 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.